Virotherapy - Cancer targeted pharmacology
Building on their success in vaccination, many groups are now exploring the use of viruses as anticancer agents. In general, viral therapeutics provide the possibility to express anticancer proteins directly at the tumour site, decreasing exposure to normal tissue during delivery and maximising ther...
Main Authors: | Tedcastle, A, Cawood, R, Di, Y, Fisher, K, Seymour, L |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2012
|
Registos relacionados
-
Virotherapy--cancer targeted pharmacology.
Por: Tedcastle, A, et al.
Publicado em: (2012) -
Tropism ablation and stealthing of oncolytic adenovirus enhances systemic delivery to tumors and improves virotherapy of cancer.
Por: Green, N, et al.
Publicado em: (2012) -
Comparison of molecular strategies for breast cancer virotherapy using oncolytic adenovirus.
Por: Bazan-Peregrino, M, et al.
Publicado em: (2008) -
Effects of Producer Cell Type on the Properties of Oncolytic Sindbis Virus
Por: Kueberuwa, G, et al.
Publicado em: (2011) -
Combining virotherapy and angiotherapy for the treatment of breast cancer.
Por: Bazan-Peregrino, M, et al.
Publicado em: (2013)